SS
SIMR develops novel biopharmaceutical drugs for pain, inflammation, and central nervous system disorders. Their research and development platform supports comprehensive drug development, from compound screening to clinical trials.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- SIMR develops novel biopharmaceutical drugs for pain, inflammation, and central nervous system disorders. Their research and development platform supports comprehensive drug development, from compound screening to clinical trials.